PSP Investments logo

PSP Investments

North America, Ontario, Canada, Ottawa

Description

PSP Investments is one of Canada’s largest pension investment managers.

Investor Profile

PSP Investments has made 25 investments, with 3 in the past 12 months and 20% as lead.

Stage Focus

  • Private Equity (24%)
  • Series E (12%)
  • Post Ipo Equity (12%)
  • Series B (12%)
  • Series A (12%)
  • Series D (8%)
  • Debt Financing (8%)
  • Series Unknown (8%)
  • Series G (4%)

Country Focus

  • United States (68%)
  • Canada (16%)
  • France (8%)
  • India (4%)
  • United Kingdom (4%)

Industry Focus

  • Biotechnology
  • Medical
  • Health Care
  • Financial Services
  • Software
  • Therapeutics
  • Manufacturing
  • Life Science
  • Information Technology
  • Enterprise Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does PSP Investments frequently co-invest with?

Alaska Permanent Fund
North America, Alaska, United States, Juneau
Co-Investments: 2
Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Goldman Sachs
North America, New York, United States, New York
Co-Investments: 2
Royal Bank of Canada
North America, Ontario, Canada, Toronto
Co-Investments: 2
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 3
T. Rowe Price
North America, Maryland, United States, Baltimore
Co-Investments: 3
CPP Investments
North America, Ontario, Canada, Toronto
Co-Investments: 4
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Flagship Pioneering
North America, Massachusetts, United States, Cambridge
Co-Investments: 4
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 2

Which angels does PSP Investments often collaborate with?

LW
North America, Washington, United States, Seattle
Shared Deals: 1

What are some of recent deals done by PSP Investments?

Ceva Santé Animale

Libourne, Aquitaine, France

Ceva Sante Animale is a veterinary health company focused on the research, development, production and marketing of pharmaceutical products.

Animal FeedBiotechnologyCannabisClinical TrialsPharmaceuticalVeterinary
Private EquityMar 31, 2025
PKF O'Connor Davies

New York, New York, United States

PKF O'Connor Davies is a full-service CPA and advisory firm that provides audit, tax, and management advisory services.

AccountingAdviceConsultingFinancial Services
Private EquityNov 18, 2024
Amount Raised: $40,000,000
Cohere

Toronto, Ontario, Canada

Cohere provides access to advanced Large Language Models and NLP tools through one easy-to-use API.

Artificial Intelligence (AI)Generative AIMachine LearningNatural Language Processing
Series DJul 22, 2024
Amount Raised: $500,000,000
Promise Robotics

Toronto, Ontario, Canada

Promise Robotics is a construction technology company for digital manufacturing and assembly of buildings.

Artificial Intelligence (AI)ConstructionIndustrial AutomationRoboticsSaaSSoftware
Series AOct 31, 2023
Amount Raised: $14,986,919
Aditya Birla Capital

Mumbai, Maharashtra, India

The financial services arm of the Aditya Birla Group.

FinanceFinancial Services
Post Ipo EquityJun 30, 2023
Amount Raised: $365,424,739
Ziply Fiber

Everett, Washington, United States

Ziply Fiber simplify and elevate the connected lives of our communities by combining the most advanced network.

InternetTelecommunications
Private EquitySep 8, 2022
Amount Raised: $450,000,000
D-Wave Systems

Burnaby, British Columbia, Canada

D-Wave Systems designs and manufactures quantum computing and superconducting electronics.

ElectronicsManufacturingQuantum ComputingSemiconductor
Post Ipo EquityAug 8, 2022
Amount Raised: $40,000,000
RefleXion Medical

Hayward, California, United States

RefleXion Medical is a developer of biologically-guided radiotherapy systems for patients with cancer.

BiotechnologyHealth CareMedicalMedical DeviceTherapeutics
Series EMar 10, 2022
Amount Raised: $80,000,000
Prime Medicine

Cambridge, Massachusetts, United States

Prime Medicine operates as a biotechnology company that delivers the promise of gene editing using Prime Editing.

BiotechnologyGeneticsLife ScienceMedical
Series BJul 13, 2021
Amount Raised: $200,000,000
Repertoire Immune Medicines

Cambridge, Massachusetts, United States

Repertoire Immune Medicines is a clinical stage biotechnology company.

BiotechnologyLife ScienceMedicalTherapeutics
Series BApr 13, 2021
Amount Raised: $189,000,000